Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Bio-Gene Technology Ltd. ( (AU:BGT) ).
Bio-Gene Technology Ltd has announced a proposed issue of securities, including unlisted options and ordinary fully paid shares, as part of a securities purchase plan and placement. This move is expected to enhance the company’s financial position, potentially enabling further development of its insecticide products and strengthening its market presence.
More about Bio-Gene Technology Ltd.
Bio-Gene Technology Ltd operates in the biotechnology industry, focusing on developing novel insecticide products aimed at addressing resistance issues in pest control. The company is committed to providing innovative solutions for agricultural and public health markets.
YTD Price Performance: -41.86%
Average Trading Volume: 153,703
Technical Sentiment Signal: Buy
Current Market Cap: A$5.03M
See more insights into BGT stock on TipRanks’ Stock Analysis page.